Unknown

Dataset Information

0

Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.


ABSTRACT: Malignant pleural mesothelioma (MPM) is a rare cancer that is refractory to current treatments. It is characterized by a robust deposition of transitional fibrin that is in part promoted by tumor cells. MPM cells express tissue factor (TF) and the tissue factor pathway inhibitor (TFPI), but their contribution to the pathogenesis of MPM has been unclear. We found that REN MPM cells fail to express TFPI. Based on the tumor growth-promoting properties of TF, we hypothesized that the stable transfection of TFPI into REN MPM cells would decrease their aggressiveness. We tested our hypothesis using in vitro, in vivo, and ex vivo analyses. TFPI knock-in decreased the proliferation, invasion, and TF activity of REN cells in vitro. REN TFPI knock-in cells, empty vector, and naive control cells were next injected intrapleurally into nude mice. The expression of TFPI significantly decreased tissue invasion, inflammation, and the deposition of fibrin and collagen associated with tumor tissue, pleural effusions, and tumor burden. In ex vivo analyses, REN cells were cultured from harvested tumors. The overexpression of TFPI was maintained in cells propagated from TFPI knock-in tumors, and attenuated the activation of Factor X and the invasiveness of tumor cells. These analyses demonstrate that TFPI reduces the aggressiveness of MPM in vitro and in vivo, and that its effect involves the inhibition of TF procoagulant activity. These observations suggest that the interactions of TF and TFPI represent a novel therapeutic target in the treatment of MPM.

SUBMITTER: Williams L 

PROVIDER: S-EPMC3297168 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.

Williams LaTerrica L   Tucker Torry A TA   Koenig Kathy K   Allen Timothy T   Rao L Vijaya Mohan LV   Pendurthi Usha U   Idell Steven S  

American journal of respiratory cell and molecular biology 20110818 2


Malignant pleural mesothelioma (MPM) is a rare cancer that is refractory to current treatments. It is characterized by a robust deposition of transitional fibrin that is in part promoted by tumor cells. MPM cells express tissue factor (TF) and the tissue factor pathway inhibitor (TFPI), but their contribution to the pathogenesis of MPM has been unclear. We found that REN MPM cells fail to express TFPI. Based on the tumor growth-promoting properties of TF, we hypothesized that the stable transfec  ...[more]

Similar Datasets

| S-EPMC2933144 | biostudies-literature
2005-06-01 | GSE2549 | GEO
| S-EPMC9454618 | biostudies-literature
2014-12-02 | GSE59180 | GEO
| S-EPMC7047444 | biostudies-literature
| S-EPMC8836658 | biostudies-literature
| S-EPMC6032160 | biostudies-literature
| S-EPMC3992494 | biostudies-literature
| S-EPMC6198256 | biostudies-literature
| S-EPMC8200040 | biostudies-literature